Cargando...
Lamivudine for preventing reactivation of hepatitis B infection in patients planned to undergo immunosuppressive therapy
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the beneficial and harmful effects of lamivudine in preventing reactivation of HBV during or following immunosuppressive therapy in HBsAg‐positive patients. To estimate the optimal time of initiating...
Guardado en:
| Publicado en: | Cochrane Database Syst Rev |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley & Sons, Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741844/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD005264.pub3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|